Monday, May 16, 2011

THAI Princess Makes Official Visit To RAMBAM

As part of ongoing cooperation between Thai research centers and Rambam Hospital in Haifa, Princess Chulabhorn of Thailand and her royal entourage visited the medical center this week. At Rambam, the princess signed a formal memorandum of understanding, paving the way for future joint efforts.

Prof. Dr. Her Royal Highness Princess Chulabhorn Mahido arrived on May 15, 2011 for an official visit at the
Rambam Health Care Campus. The princess was accompanied by her royal entourage and by representatives of the Thai embassy in Israel, the Ministry of Foreign Affairs and the Municipality of Haifa.

This marks the sixth visit to Israel of the princess, the youngest daughter of King Bhumibol Adulyadej and Queen Sirikit of Thailand. This current visit is being held as part of scientific cooperation between Thai and Israeli research organizations. Within this initiative, Rambam is conducting cancer research with Thailand’s prestigious
Chulabhorn Research Institute.

In addition to her royal title, the princess is a Doctor of Biochemistry, and is committed to advancing scientific research in her home country. Likewise, she heads the research center that bears her name, and lectures at different academic institutions. The princess oversees funds that grant scholarships and prizes to researchers, and is a senior member of the UK's Royal Society of Chemistry. In 1986, UNESCO awarded her the Einstein Medal for her promotion of international scientific cooperation.

Upon her arrival to Rambam, the princess was greeted by representatives of the hospital administration. She then attended a seminar delivered by different Rambam researchers and physicians. Opening this event, Rambam Director Prof Rafi Beyar stated that in the last three years, “Delegations from both sides have been cooperating in the fields of oncology and cancer imaging. There is no doubt in my mind,” he continued, “that within ten years, the field of oncology will be transformed through breakthrough technology and a deeper understanding of genetics, imaging, personalized medicine and tailored treatment.”

No comments: